Insider Selling: Allstate (NYSE:ALL) Insider Sells 3,786 Shares of Stock

Market Beat
2025.12.03 00:50
portai
I'm PortAI, I can summarize articles.

Allstate Corporation insider Suren Gupta sold 3,786 shares at $215.13 each, totaling $814,482.18. This sale reduced Gupta's holdings by 3.63%, leaving him with 100,646 shares valued at $21,651,973.98. The transaction was disclosed in an SEC filing. Gupta has made several other sales recently, and Allstate's stock performance shows a recent decline, with a market cap of $54.98 billion. The company reported strong quarterly earnings and announced a $1.00 per share dividend.

The Allstate Corporation (NYSE:ALL - Get Free Report) insider Suren Gupta sold 3,786 shares of the company's stock in a transaction on Friday, November 28th. The shares were sold at an average price of $215.13, for a total transaction of $814,482.18. Following the completion of the sale, the insider directly owned 100,646 shares in the company, valued at $21,651,973.98. This trade represents a 3.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • Why Insurance Stocks May Struggle Despite Strong Highs

Suren Gupta also recently made the following trade(s):

  • On Wednesday, November 26th, Suren Gupta sold 750 shares of Allstate stock. The shares were sold at an average price of $215.01, for a total transaction of $161,257.50.
  • On Monday, November 24th, Suren Gupta sold 600 shares of Allstate stock. The stock was sold at an average price of $215.02, for a total value of $129,012.00.
  • On Friday, November 21st, Suren Gupta sold 21,871 shares of Allstate stock. The shares were sold at an average price of $215.21, for a total value of $4,706,857.91.
  • On Monday, November 17th, Suren Gupta sold 400 shares of Allstate stock. The shares were sold at an average price of $215.22, for a total value of $86,088.00.
  • On Friday, November 14th, Suren Gupta sold 1,400 shares of Allstate stock. The stock was sold at an average price of $215.02, for a total value of $301,028.00.

Allstate Stock Performance

Shares of ALL traded down $2.88 during trading hours on Monday, hitting $210.10. The stock had a trading volume of 1,696,862 shares, compared to its average volume of 1,632,624. The firm has a 50-day moving average price of $204.68 and a 200 day moving average price of $202.45. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. The Allstate Corporation has a fifty-two week low of $176.00 and a fifty-two week high of $215.89. The firm has a market capitalization of $54.98 billion, a price-to-earnings ratio of 9.88, a PEG ratio of 0.69 and a beta of 0.35.

  • 3 Sector ETFs Catching Fire After Earnings Beats

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share for the quarter, beating the consensus estimate of $5.48 by $5.69. The firm had revenue of $17.26 billion during the quarter, compared to analyst estimates of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%.Allstate's revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.91 EPS. As a group, research analysts anticipate that The Allstate Corporation will post 18.74 EPS for the current year.

Allstate Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be given a dividend of $1.00 per share. The ex-dividend date is Monday, December 1st. This represents a $4.00 dividend on an annualized basis and a yield of 1.9%. Allstate's dividend payout ratio is currently 12.95%.

Hedge Funds Weigh In On Allstate

  • 6 Stocks Poised to Benefit From a Trade War in Unexpected Ways

Several large investors have recently bought and sold shares of ALL. Cambria Investment Management L.P. acquired a new stake in shares of Allstate during the third quarter worth about $466,000. Vermillion & White Wealth Management Group LLC grew its position in shares of Allstate by 14.5% during the third quarter. Vermillion & White Wealth Management Group LLC now owns 1,262 shares of the insurance provider's stock worth $271,000 after acquiring an additional 160 shares during the last quarter. CIBC Private Wealth Group LLC increased its holdings in shares of Allstate by 11.3% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 17,204 shares of the insurance provider's stock valued at $3,693,000 after acquiring an additional 1,741 shares during the period. CIBC Bancorp USA Inc. purchased a new stake in Allstate in the 3rd quarter valued at $7,814,000. Finally, Chartist Inc. CA acquired a new stake in Allstate during the 3rd quarter worth $518,000. Institutional investors and hedge funds own 76.47% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Weiss Ratings restated a "buy (b)" rating on shares of Allstate in a research report on Wednesday, October 8th. UBS Group increased their price target on shares of Allstate from $250.00 to $255.00 and gave the company a "buy" rating in a research note on Monday, November 10th. Raymond James Financial reaffirmed a "strong-buy" rating and set a $260.00 price objective (up previously from $250.00) on shares of Allstate in a research report on Monday, August 4th. BMO Capital Markets lifted their price objective on Allstate from $235.00 to $244.00 and gave the company an "outperform" rating in a research note on Friday, November 7th. Finally, Keefe, Bruyette & Woods lifted their target price on Allstate from $246.00 to $250.00 and gave the company an "outperform" rating in a research report on Tuesday, November 11th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $237.92.

Read Our Latest Stock Report on ALL

Allstate Company Profile

(Get Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Further Reading

  • Five stocks we like better than Allstate
  • What is a support level?
  • Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
  • Manufacturing Stocks Investing
  • Congress Beat the Market Again—Here Are the 3 Stocks They Bought
  • How to Most Effectively Use the MarketBeat Earnings Screener
  • Go on a Shopping Spree With 3 Top Retail ETFs

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here